Chief Accounting Officer · Cardiff Oncology, Inc. · Cardiff Oncology, Inc. — Stock Options
Side
A
Value
—
Shares
200.0K
Price
—
Executed
Feb 13, 2026
Disclosed
Feb 18, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Feb 13 executedFeb 18, 2026 disclosed
CRDF · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+9 / 25
No reported dollar value · 24.2% of prior position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lindsay Brigitte Ute filed this Form 4 reporting a grant or award of CRDF on Feb 13, 2026. It became public on Feb 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Accounting Officer
Lindsay Brigitte Utecik:0002110286
Issuer
Cardiff Oncology, Inc.cik:0001213037
Revision history · 0
No field has changed since this record was first ingested.
